Amelia Armour

Partner in the Early Stage Fund

Location

Cambridge

Areas

Intelligence, Planet

Bio

Amelia joined Amadeus Capital Partners in 2009 and is a Partner in the Early Stage Fund. Her current investment focus is on AI & Cybersecurity, Photonics & Quantum, Digital Health & MedTech and Novel Materials.

She is a Director on several boards including Xampla, who have developed novel plant-based materials to replace single-use plastics; iPronics who are building lossless optical switches for AI networking at the speed of light ; Riverlane a developer of the operating system for error corrected quantum computers; sprout.ai a provider of fast and accurate insurance claims automation and SLAMcore, a spin-out from Imperial College, developing spatial intelligence for autonomous robotics and drones.

Amelia Armour poses for a portrait photo in an open plan office environment for Amadeus Capital Partners.

“Truly innovative AI was never part of any bubble to begin with, as it provides real value to companies and people that’s evidenced by revenue which keeps pace with investment valuations.”

What we look for when investing in AI

Amelia is also an active board observer at Paragraf, the first company to mass produce graphene-based electronic devices.

Prior to Amadeus, she worked at Barclays Investment Bank as a manager in the structured capital markets team with responsibility for running a portfolio of multi-jurisdiction transactions. Amelia has also worked in structured finance at the Commonwealth Bank of Australia. She qualified as a chartered accountant with Deloitte in London in the corporate tax department.

Amelia joined the UK Government’s Semiconductor Advisory Panel in August 2023, established to deliver the National Semiconductor Strategy. She is a mentor on the Judge Business School’s Accelerate Programme and holds a BSc in Chemistry and Biology from Durham University.

Team